Exploration of the Pleural Cavity Using a fleXible endoscoPe

NCT ID: NCT02463955

Last Updated: 2016-08-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-31

Study Completion Date

2016-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

EXPLORE is a first-in-human study of single port transdiaphragmatic thoracoscopy using a flexible gastro-intestinal endoscope under two-lung ventilation with controlled capnothorax.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Thoracoscopy is usually performed either with rigid thoracoscopes, or with flexible bronchoscopes. The latter is less invasive and less expensive, but flexible bronchoscopes are difficult to manipulate within the pleural cavity and do not provide an adequate orientation within the pleural space. It is therefore associated with a lower diagnostic yield than thoracoscopy with rigid thoracoscopes. On the other hand, rigid thoracoscopes are associated with more pain, a higher cost, and usually require one-lung ventilation. Gastro-intestinal endoscopes allow a better orientation than bronchoscopes in cavities, and have wider operative channels. The EXPLORE study investigates the feasibility and safety of single port transdiaphragmatic thoracoscopy using a flexible gastro-intestinal endoscope under two-lung ventilation with controlled capnothorax.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pleural Effusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Thoracoscopy

1. experimental intervention (flexible video endoscope)
2. reference procedure (video-rigid thoracoscope)

Group Type EXPERIMENTAL

flexible video endoscope

Intervention Type DEVICE

Thoracoscopy is done using flexible video endoscope

video-rigid thoracoscope

Intervention Type DEVICE

Thoracoscopy is done using video-rigid thoracoscope

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

flexible video endoscope

Thoracoscopy is done using flexible video endoscope

Intervention Type DEVICE

video-rigid thoracoscope

Thoracoscopy is done using video-rigid thoracoscope

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of pleural effusion affirmed by chest radiography,
* Indication thoracoscopy, asked by the pulmonologist or thoracic surgeon for diagnostic investigation and / or pleural symphysis
* Inpatient or outpatient,
* Women of childbearing age having an effective contraceptive coverage (combined oral contraceptives or intrauterine device or tubal ligation); a negative pregnancy test should be obtained,
* For postmenopausal women, menopause confirmation of diagnosis,

Exclusion Criteria

* Pleural effusion compression,
* Pleural effusion infected or suspected of infection,
* Febrile patient (\> 38 ° C)
* Parapneumonic effusion
* Immunosuppression (eg, neutropenia \<1G / L, immunosuppressive therapy, ...)
* Portage known multidrug-resistant germ or S. aureus resistant to methicillin,
* Clinical suspicion of tuberculosis,
* Patients who have already been treated by pleurodesis,
* Contraindication to general anesthesia,
* Contraindication of prophylactic antibiotics,
* Contraindication to pleurodesis agent
* Increased bleeding risk,
* No one deprived of liberty by an administrative or judicial decision or protected adult subject (under guardianship)
* Pregnant or breastfeeding women.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Rouen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

BASTE Jean Marc, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Rouen

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014-A01660-47

Identifier Type: OTHER

Identifier Source: secondary_id

2014/182/HP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.